bullish
Pre-IPO Sirnaomics Ltd. - Cautious Optimism Is Still Recommended
249 Views29 Sep 2021 09:08
This article mainly analyzed Sirnaomics in terms of the industry characteristics, the delivery platforms, the pipeline and the concerns of the Company.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- China Healthcare Weekly (Jan.13)- Tigermed, HBM, Brii, Jacobio, Dental Implant, Successful Investors15 Jan 2023
- People's Insurance (PICC) (1339.HK) - The Rally (If Any) May Not Last Despite Undervalued08 Sep 2022
- Sirnaomics (2257.HK)-Unverified Technology and Uncertainties Can Lead to Big Swings in Share Price07 Sep 2022
- Pre-IPO Sirnaomics Ltd. - Cautious Optimism Is Still Recommended29 Sep 2021
- WuXi AppTec (603259.CH/2359.HK) - The Smart Business Model21 Sep 2021
- CanSino Biologics (688185.CH/6185.HK) 2021/1H - Concerns on Key Products and the Outlook07 Sep 2021
- Innovent Biologics (1801.HK) - The Strength and the Concerns31 Aug 2021
x